Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06141135

GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
240 (estimated)
Sponsor
Genomic Prediction Inc. · Industry
Sex
Female
Age
35 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Detailed description

In this randomized controlled trial, a total of 240 patients divided evenly across the two participating IVF center will be recruited. Patients will be randomized to a control and to a treatment group, each containing 120 participants. Only patients with at least one evaluable blastocyst will be randomized. Patients will undergo ovarian hyper-stimulation, oocyte retrieval, fertilization and embryo culture per standard clinical protocol determined by IVF center. In the control arm, patients will undergo a single frozen embryo transferof the untested, best quality blastocyst. All other blastocysts with lower morphology will undergo trophectoderm biopsy on day 5, 6 or 7 and will be frozen. PGT-A results of the untransferred embryos will be revealed to the patient AFTER the outcome of the initial ET is known. In the experimental arm, all embryos will be cultured to blastocyst and all viable blastocysts will undergo trophectoderm biopsy and PGT-A. PGT-A will be performed regardless of the number of blastocysts available. Patients will undergo frozen transfer of the single, best quality euploid blastocyst. If the initial transfer results in a non-conception cycle and additional embryos are available for transfer.

Conditions

Interventions

TypeNameDescription
OTHERPreimplantation genetic testing for aneuploidy (PGTA)24 chromosome screening for aneuploidy in the preimplantation embryo(blastocyst stage)

Timeline

Start date
2023-11-15
Primary completion
2025-11-15
Completion
2026-11-15
First posted
2023-11-21
Last updated
2025-08-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06141135. Inclusion in this directory is not an endorsement.